Efficacy Investigation of Kuntai Capsule for the Add-back Therapy of GnRH-a Administration to Endometriosis Patients with Conservative Surgery

Phase 4

• Conditions: endometriosis

• Registration Number: ITMCTR1900002879
• Lead Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Laparoscopic diagnosis of endometriosis;
2. Perform conservative surgery to cut or destroy all visible ectopic endometrial lesions;
3. Consent to GnRH-a treatment after surgery;
4. Sign informed consent and volunteer to join the study.

Exclusion Criteria

1. Suspected or confirmed malignant tumor patients;
2. Patients with adenomyosis or uterine fibroids;
3. Application of drugs that affect ovarian function such as oral contraceptives, GnRHa analogs, danazol, and Zishen Yutai Wan within the past 3 months;
4. Those who are allergic to the drugs in the trial;
5. Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney or hematopoietic system or mental illness;
6. Suspected or have a history of alcohol or drug abuse, or other diseases or conditions that reduce or complicate enrollment according to the investigator's judgment, such as frequent changes in the work environment and unstable living environment. Loss of follow-up;
7. Other patients identified by the investigator as inappropriate for this study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS score;Kupperman score;

Secondary Outcome Measures

Name	Time	Method
FSH;AFC;E2;LH;CA125;